← Back to Clinical Trials
Recruiting NCT04956185

NCT04956185 Data Collection of Patients Admitted to the Stroke Unit

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04956185
Status Recruiting
Phase
Sponsor University Hospital, Ghent
Condition Stroke
Study Type OBSERVATIONAL
Enrollment 5,000 participants
Start Date 2021-04-29
Primary Completion 2031-02-01

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 5,000 participants in total. It began in 2021-04-29 with a primary completion date of 2031-02-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this prospective observational study is to create a database in which data will be collected from every patient admitted to the Stroke unit and who has explicitly given his or her informed consent for this data collection. The data that will be collected are part of the standard clinical data. No additional investigations, blood tests or any other tests will be performed. The purpose of this database is to conduct retrospective observational research in the future and will allow the hospital to keep track of some important quality indicators in stroke care.

Eligibility Criteria

Inclusion Criteria: * Patients admitted to the Stroke unit with a cerebrovascular disease * Patients admitted to the regular neurological ward or any other department in the University Hospital Ghent with a cerebrovascular disease who are actively followed by the department of Neurology during hospitalisation * Patients who have given their explicit informed consent for data collection Exclusion Criteria: * Patients who have not given informed consent for data collection * Patients who are not able to give informed consent and whose legal representative has not given informed consent

Contact & Investigator

Central Contact

Veerle De Herdt, MD PhD

✉ veerle.deherdt@uzgent.be

📞 +3293326481

Frequently Asked Questions

Who can join the NCT04956185 clinical trial?

This trial is open to participants of all sexes, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04956185 currently recruiting?

Yes, NCT04956185 is actively recruiting participants. Contact the research team at veerle.deherdt@uzgent.be for enrollment information.

Where is the NCT04956185 trial being conducted?

This trial is being conducted at Ghent, Belgium.

Who is sponsoring the NCT04956185 clinical trial?

NCT04956185 is sponsored by University Hospital, Ghent. The trial plans to enroll 5,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology